Epidermal growth factor vs best supportive care
Adverse effects: at least one serious adverse event · People with advanced non‐small cell lung cancer
Epidermal growth factor showed no clear difference in participants with at least one serious adverse event compared with best supportive care (low certainty).
1 finding from 1 review
- RR 1.32 [0.88, 1.98]2 studies · 458 participantsLow